세계의 세포배양 배지 백 시장(-2032년) : 제품 유형별, 용량별, 용도별, 재료별, 정제 단계별, 지역별

Cell Culture Media Bags Market Research Report By Product Type (Stirred Tank Bioreactors, Wave Bioreactors, Gas Permeable Bags, Single-Use Bioreactors), By Capacity (Up to 50L, 50L to 500L, 500L to 1,000L, Over 1,000L), By Application (Monoclonal Antibody Production, Recombinant Protein Production, Cell-Based Therapy, Virus Propagation), By Material Type (Polypropylene, Polyethylene, Polystyrene, Biodegradable Materials), By Purification Stage (Process Development, Pilot Scale, Production Scale) and By Region Industry Forecast to 2032

Market Overview

In 2023, the cell culture media sacks market size was estimated to be USD 1.11 billion, according to the MRFR analysis. The industry is anticipated to experience a compound annual growth rate (CAGR) of 5.77% from USD 1.17 billion in 2024 to USD 1.83 billion by 2032 during the forecast period (2024-2032).

The demand for cell-based therapies, the increasing use of bioreactors in cell culture, and the necessity for cost-effective and efficient media storage and transportation are the primary market drivers for cell culture media sacks. Potential market opportunities include the integration of sensors and monitoring systems, the development of novel biomaterials for media bags, and the expansion into emerging economies. The cell culture media bags market has experienced a recent trend of a transition toward single-use systems, the adoption of advanced manufacturing technologies, and a heightened emphasis on environmental impact and sustainability.

Market segment insights

The Cell Culture Media Bags Market is segmented by product type into agitated tank bioreactors, wave bioreactors, gas permeable bags, and single-use bioreactors.

The market is divided into four segments based on capacity: 'Up to 50L', '50L to 500L', '500L to 1,000L', and 'Over 1,000L'.

Polypropylene, polyethylene, polystyrene, and biodegradable materials comprise the Cell Culture Media Bags Market.

The market segmentation by Purification Stage, which is divided into Process Development, Pilot Scale, and Production Scale, offers valuable insights into the industry's dynamics.

Regional Perspectives

The Cell Culture Media Bags Market is divided into the following regions: North America, Europe, APAC, South America, and MEA. In 2023, North America constituted the largest regional segment, comprising more than 40% of the global market. The demand for cell culture media sacks is being driven by the presence of numerous pharmaceutical and biotechnology companies in the region. With a market share exceeding 30%, Europe is the second largest regional segment. A robust healthcare system and a developing biopharmaceutical industry are present in the region. APAC is the most rapidly expanding regional segment, with a compound annual growth rate (CAGR) exceeding 5%. The demand for cell culture media sacks is being driven by the presence of numerous emerging markets in the region. The combined market share of South America and MEA is less than 10%, making them the smallest regional segments. Nevertheless, it is anticipated that these regions will experience substantial growth in the years ahead.

Major Players

Cytiva, Merck KGaA, ATCC, STEMCELL Technologies, PromoCell GmBH, Himedia Laboratories Pvt. Ltd., Danaher, Corning, Lonza Group AG, BioVectra, BD Biosciences, Sartorius, Thermo Fisher Scientific, and GE Healthcare are among the key companies in the Cell Culture Media Bags Market.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

• 1.1. MARKET OVERVIEW
• 1.2. KEY FINDINGS
• 1.3. MARKET SEGMENTATION
• 1.4. COMPETITIVE LANDSCAPE
• 1.5. CHALLENGES AND OPPORTUNITIES
• 1.6. FUTURE OUTLOOK

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTION
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING MODEL
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. VALUE CHAIN ANALYSIS
• 5.2. PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. MARKET IMPACT ANALYSIS
  • 5.3.2. REGIONAL IMPACT
  • 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. CELL CULTURE MEDIA BAGS MARKET, BY PRODUCT TYPE (USD BILLION)

• 6.1. STIRRED TANK BIOREACTORS
• 6.2. WAVE BIOREACTORS
• 6.3. GAS PERMEABLE BAGS
• 6.4. SINGLE-USE BIOREACTORS

7. CELL CULTURE MEDIA BAGS MARKET, BY CAPACITY (USD BILLION)

• 7.1. UP TO 50L
• 7.2. 50L TO 500L
• 7.3. 500L TO 1,000L
• 7.4. OVER 1,000L

8. CELL CULTURE MEDIA BAGS MARKET, BY APPLICATION (USD BILLION)

• 8.1. MONOCLONAL ANTIBODY PRODUCTION
• 8.2. RECOMBINANT PROTEIN PRODUCTION
• 8.3. CELL-BASED THERAPY
• 8.4. VIRUS PROPAGATION

9. CELL CULTURE MEDIA BAGS MARKET, BY MATERIAL TYPE (USD BILLION)

• 9.1. POLYPROPYLENE
• 9.2. POLYETHYLENE
• 9.3. POLYSTYRENE
• 9.4. BIODEGRADABLE MATERIALS

10. CELL CULTURE MEDIA BAGS MARKET, BY PURIFICATION STAGE (USD BILLION)

• 10.1. PROCESS DEVELOPMENT
• 10.2. PILOT SCALE
• 10.3. PRODUCTION SCALE

11. CELL CULTURE MEDIA BAGS MARKET, BY REGIONAL (USD BILLION)

• 11.1. NORTH AMERICA
  • 11.1.1. US
  • 11.1.2. CANADA
• 11.2. EUROPE
  • 11.2.1. GERMANY
  • 11.2.2. UK
  • 11.2.3. FRANCE
  • 11.2.4. RUSSIA
  • 11.2.5. ITALY
  • 11.2.6. SPAIN
  • 11.2.7. REST OF EUROPE
• 11.3. APAC
  • 11.3.1. CHINA
  • 11.3.2. INDIA
  • 11.3.3. JAPAN
  • 11.3.4. SOUTH KOREA
  • 11.3.5. MALAYSIA
  • 11.3.6. THAILAND
  • 11.3.7. INDONESIA
  • 11.3.8. REST OF APAC
• 11.4. SOUTH AMERICA
  • 11.4.1. BRAZIL
  • 11.4.2. MEXICO
  • 11.4.3. ARGENTINA
  • 11.4.4. REST OF SOUTH AMERICA
• 11.5. MEA
  • 11.5.1. GCC COUNTRIES
  • 11.5.2. SOUTH AFRICA
  • 11.5.3. REST OF MEA

12. COMPETITIVE LANDSCAPE

• 12.1. OVERVIEW
• 12.2. COMPETITIVE ANALYSIS
• 12.3. MARKET SHARE ANALYSIS
• 12.4. MAJOR GROWTH STRATEGY IN THE CELL CULTURE MEDIA BAGS MARKET
• 12.5. COMPETITIVE BENCHMARKING
• 12.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE CELL CULTURE MEDIA BAGS MARKET
• 12.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 12.7.1. NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT
  • 12.7.2. MERGER & ACQUISITIONS
  • 12.7.3. JOINT VENTURES
• 12.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 12.8.1. SALES AND OPERATING INCOME
  • 12.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2023

13. COMPANY PROFILES

• 13.1. CYTIVA
  • 13.1.1. FINANCIAL OVERVIEW
  • 13.1.2. PRODUCTS OFFERED
  • 13.1.3. KEY DEVELOPMENTS
  • 13.1.4. SWOT ANALYSIS
  • 13.1.5. KEY STRATEGIES
• 13.2. MERCK KGAA
  • 13.2.1. FINANCIAL OVERVIEW
  • 13.2.2. PRODUCTS OFFERED
  • 13.2.3. KEY DEVELOPMENTS
  • 13.2.4. SWOT ANALYSIS
  • 13.2.5. KEY STRATEGIES
• 13.3. ATCC
  • 13.3.1. FINANCIAL OVERVIEW
  • 13.3.2. PRODUCTS OFFERED
  • 13.3.3. KEY DEVELOPMENTS
  • 13.3.4. SWOT ANALYSIS
  • 13.3.5. KEY STRATEGIES
• 13.4. STEMCELL TECHNOLOGIES
  • 13.4.1. FINANCIAL OVERVIEW
  • 13.4.2. PRODUCTS OFFERED
  • 13.4.3. KEY DEVELOPMENTS
  • 13.4.4. SWOT ANALYSIS
  • 13.4.5. KEY STRATEGIES
• 13.5. PROMOCELL GMBH
  • 13.5.1. FINANCIAL OVERVIEW
  • 13.5.2. PRODUCTS OFFERED
  • 13.5.3. KEY DEVELOPMENTS
  • 13.5.4. SWOT ANALYSIS
  • 13.5.5. KEY STRATEGIES
• 13.6. HIMEDIA LABORATORIES PVT. LTD.
  • 13.6.1. FINANCIAL OVERVIEW
  • 13.6.2. PRODUCTS OFFERED
  • 13.6.3. KEY DEVELOPMENTS
  • 13.6.4. SWOT ANALYSIS
  • 13.6.5. KEY STRATEGIES
• 13.7. DANAHER
  • 13.7.1. FINANCIAL OVERVIEW
  • 13.7.2. PRODUCTS OFFERED
  • 13.7.3. KEY DEVELOPMENTS
  • 13.7.4. SWOT ANALYSIS
  • 13.7.5. KEY STRATEGIES
• 13.8. CORNING
  • 13.8.1. FINANCIAL OVERVIEW
  • 13.8.2. PRODUCTS OFFERED
  • 13.8.3. KEY DEVELOPMENTS
  • 13.8.4. SWOT ANALYSIS
  • 13.8.5. KEY STRATEGIES
• 13.9. LONZA GROUP AG
  • 13.9.1. FINANCIAL OVERVIEW
  • 13.9.2. PRODUCTS OFFERED
  • 13.9.3. KEY DEVELOPMENTS
  • 13.9.4. SWOT ANALYSIS
  • 13.9.5. KEY STRATEGIES
• 13.10. BIOVECTRA
  • 13.10.1. FINANCIAL OVERVIEW
  • 13.10.2. PRODUCTS OFFERED
  • 13.10.3. KEY DEVELOPMENTS
  • 13.10.4. SWOT ANALYSIS
  • 13.10.5. KEY STRATEGIES
• 13.11. BD BIOSCIENCES
  • 13.11.1. FINANCIAL OVERVIEW
  • 13.11.2. PRODUCTS OFFERED
  • 13.11.3. KEY DEVELOPMENTS
  • 13.11.4. SWOT ANALYSIS
  • 13.11.5. KEY STRATEGIES
• 13.12. SARTORIUS
  • 13.12.1. FINANCIAL OVERVIEW
  • 13.12.2. PRODUCTS OFFERED
  • 13.12.3. KEY DEVELOPMENTS
  • 13.12.4. SWOT ANALYSIS
  • 13.12.5. KEY STRATEGIES
• 13.13. THERMO FISHER SCIENTIFIC
  • 13.13.1. FINANCIAL OVERVIEW
  • 13.13.2. PRODUCTS OFFERED
  • 13.13.3. KEY DEVELOPMENTS
  • 13.13.4. SWOT ANALYSIS
  • 13.13.5. KEY STRATEGIES
• 13.14. GE HEALTHCARE
  • 13.14.1. FINANCIAL OVERVIEW
  • 13.14.2. PRODUCTS OFFERED
  • 13.14.3. KEY DEVELOPMENTS
  • 13.14.4. SWOT ANALYSIS
  • 13.14.5. KEY STRATEGIES

14. APPENDIX

• 14.1. REFERENCES
• 14.2. RELATED REPORTS